2014
DOI: 10.1016/j.ajem.2013.11.036
|View full text |Cite
|
Sign up to set email alerts
|

High-dose vitamin C management in dapsone-induced methemoglobinemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
33
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(34 citation statements)
references
References 8 publications
0
33
0
1
Order By: Relevance
“…Studies on vitamin E have found no effect [26] or a partial protective effect when 800 units were administered for 4 weeks [27]. Studies on vitamin C doses that are >1 m M (attainable by intravenous administration) have found methemoglobinemia reduction; however, oral administration cannot exceed 200 µ M because of the gastrointestinal absorption [28,29,30]. Studies on the cytochrome P450 inhibitor cimetidine in rats and small studies on humans have found that concurrent administration reduces levels of methemoglobinemia [31,32].…”
Section: Discussionmentioning
confidence: 99%
“…Studies on vitamin E have found no effect [26] or a partial protective effect when 800 units were administered for 4 weeks [27]. Studies on vitamin C doses that are >1 m M (attainable by intravenous administration) have found methemoglobinemia reduction; however, oral administration cannot exceed 200 µ M because of the gastrointestinal absorption [28,29,30]. Studies on the cytochrome P450 inhibitor cimetidine in rats and small studies on humans have found that concurrent administration reduces levels of methemoglobinemia [31,32].…”
Section: Discussionmentioning
confidence: 99%
“…Numerous in vitro studies have shown that ascorbic acid (vitamin C) can treat methaemoglobinaemia by removing key precursors of oxidative damage and reducing methaemoglobin 26. In a case report from Korea, Park and Lee described the use of high-dose intravenous ascorbic acid (10 g four times a day) for the treatment of methaemoglobinaemia (due to non-availability of methylene blue) 27. However, in the case reported by Park and Lee, the patient did not have G6PD deficiency.…”
Section: Discussionmentioning
confidence: 99%
“…Dosing for ascorbic acid in patients with G6PD is 300-1000mg per day orally in divided doses. In most patients, MB is preferred to ascorbic acid because of its rapid onset of action [17,22].…”
Section: Discussionmentioning
confidence: 99%